On the other hand, therapeutic targeting of the FTO with a Lenti-FTO approach reversed the GDM-mediated increase in β-gal expression, decrease in mitochondrial OCR, and apoptosis-related markers (BAX and Bcl-2) in neonatal cardiomyocytes. The gene discussed is BAX; the disease is gestational diabetes.